Deborah D. Persaud

Deborah D. Persaud

Pediatric Infectious Disease

Rubenstein BLDG Lower Level
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

Journal: Science translational medicine

Published: May 06, 2026

Quantification and localization of integrated HIV-1 in memory and naïve CD4+ T cells from adolescents and young adults with perinatally-acquired HIV-1.

Quantification and localization of integrated HIV-1 in memory and naïve CD4+ T cells from adolescents and young adults with perinatally-acquired HIV-1.

Journal: PLoS pathogens

Published: December 28, 2025

HIV Cure Research: Ethical and Real-World Practical Considerations for Pediatric and Adolescent Populations.

HIV Cure Research: Ethical and Real-World Practical Considerations for Pediatric and Adolescent Populations.

Journal: Journal of the Pediatric Infectious Diseases Society

Published: September 23, 2025

Dynamics of Intact and Defective Human Immunodeficiency Virus Type 1 (HIV-1) Proviruses During Decades of Suppressive Antiretroviral Treatment in Young Adults With Perinatal HIV.

Dynamics of Intact and Defective Human Immunodeficiency Virus Type 1 (HIV-1) Proviruses During Decades of Suppressive Antiretroviral Treatment in Young Adults With Perinatal HIV.

Journal: The Journal of infectious diseases

Published: August 19, 2025

Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials.

Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials.

Journal: The lancet. HIV

Published: July 14, 2025

Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central Africa.

Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central Africa.

Journal: Journal of virus eradication

Published: May 15, 2025

The time is now to use the tools we have to end AIDS in children.

The time is now to use the tools we have to end AIDS in children.

Journal: Journal of the International AIDS Society

Published: May 03, 2025

ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study.

ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study.

Journal: The lancet. HIV

Published: April 04, 2025

Research Toward a Cure for Perinatal HIV.

Research Toward a Cure for Perinatal HIV.

Journal: Clinics in perinatology

Published: November 01, 2024

HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.

HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.

Journal: AIDS research and human retroviruses

Published: October 28, 2024

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.

Journal: The New England journal of medicine

Published: July 24, 2024

Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.

Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.

Journal: AIDS (London, England)

Published: May 30, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026